Le Lézard
Classified in: Health
Subjects: AWD, LEG

The Inner Circle Acknowledges, Barry I. Gold Pinnacle Lifetime Member


OAKLAND, N.J., Jan. 2, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Barry I. Gold, is acknowledged as a Pinnacle Lifetime Member for his contributions as a Retired Pharmacology and Author.    

Barry I. Gold, a retired pharmacologist and accomplished author, has dedicated his career to addressing critical issues in the field of chemical pharmacology and advocating for addiction awareness and effective treatments. His expertise and advocacy have made hi

With a background in chemical pharmacology, Barry I. Gold has contributed significantly to the field through his published works and research. His passion for addressing addiction issues has driven him to write a thought-provoking book titled "We're Overdosed," which provides a comprehensive exploration of the history of opioids and the urgent need for effective addiction treatment.

One of Barry's primary advocacy focuses is the importance of addressing addiction through federal legislation. He emphasizes the need for comprehensive measures to prevent the illicit drug trade and ensure individuals have access to evidence-based addiction treatments. His work underscores the critical role that federal legislation plays in curbing addiction and saving lives.

As a retired pharmacologist and accomplished author, Barry I. Gold's contributions extend beyond his professional expertise. He is an active member of the American Society for Pharmacology and Experimental Therapeutics (ASPET), highlighting his dedication to staying connected with the latest advancements in pharmacology and research.

While Barry's professional achievements are significant, he also values the support and love of his children, expressing his gratitude for their unwavering encouragement throughout his journey.

Barry's academic journey includes a Bachelor of Science (B.S.) in Zoology from the University of Cincinnati, a Ph.D. in Pharmacology from Boston University, and a postdoctoral fellowship at Yale University School of Medicine.

Beyond his professional pursuits, Barry enjoys spending time with his family and pursuing his passion for writing. His favorite vacation place is North Carolina, where he finds inspiration and relaxation.

Although he is retired, Barry I. Gold's commitment to addressing addiction and advocating for evidence-based treatments remains steadfast. He believes in the importance of being prepared to pivot if one makes an error in their career choice, emphasizing the need for adaptability and a commitment to making a positive impact.

Barry's career accomplishments are highlighted by his books, and he is currently working on a new project titled "Boomer Dad," reflecting his continued dedication to sharing insights and knowledge with the world.

Barry I. Gold's scientific perspective and advocacy for addiction awareness serve as a source of inspiration for the medical community and individuals striving to make a difference in the field of pharmacology and addiction treatment.

Contact: Katherine Green, 516-825-5634, [email protected]

SOURCE The Inner Circle


These press releases may also interest you

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 07:00
Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of two posters on TERLIVAZ® (terlipressin) for injection in patients with hepatorenal syndrome (HRS) with rapid reduction in kidney function1 at the 2024...

17 mai 2024
Family Braces, Calgary's largest group of orthodontists with five locations across the city, reports a strong start to the second quarter of 2024. This positive momentum builds on the group's successful first quarter, underlining its...

17 mai 2024
American Skin Association (ASA) announced the recipients of the 2024 Inaugural Founders Award and the 2024 Research Achievement Awards at the 2024 Society for Investigative Dermatology (SID) Annual Meeting. ...



News published on and distributed by: